Saturday, July 2, 2022

Covaxin from Bharat Biotech has been approved for phase 2/3 trials on children aged 2 to 18.

The Central Drugs Standard Control Organization’s (CDSCO) Subject Expert Committee on COVID-19 met on Tuesday to discuss Bharat Biotech’s application to perform phase II/III clinical trials in children aged 2 to 18 years to assess the efficacy, reactogenicity, and immunogenicity of Covaxin jabs. Covaxin, a COVID-19 vaccine developed by Bharat Biotech of Hyderabad, has received clearance from an expert panel to perform phase 2/3 trials on children aged 2 to 18 years.

On Tuesday, an expert panel (Subject Expert Committee) recommended the drug maker’s anti-COVID vaccine for phase II/III clinical trials on children aged two to eighteen years, according to news agency PTI.

The trial will be conducted in 525 subjects at different locations, including AIIMS Delhi, AIIMS Patna, and Meditrina Institute of Medical Sciences in Nagpur, according to official sources.

The Central Drugs Standard Control Organization’s (CDSCO) Subject Expert Committee on COVID-19 met on Tuesday to discuss Bharat Biotech’s application to perform phase II/III clinical trials in children aged 2 to 18 years to assess the efficacy, reactogenicity, and immunogenicity of Covaxin jabs.

The idea had previously been discussed at an SEC meeting on February 24, and the company had been asked to request a revised clinical trial protocol.

ALSO CHECK: Get a tremendous discount with Firsrtcry Coupon Code and Mamaearth Coupons

Adults are being vaccinated with Covaxin, an indigenously produced vaccine by Bharat Biotech in partnership with the Indian Council of Medical Research (ICMR).

The drugmaker announced on Tuesday that it will maintain a steady supply of its COVID-19 vaccine, Covaxin, which has been sent directly to 18 states since May 1.

“Since May 1st, COVAXIN has been sent directly to 18 states. We will continue to supply our #vaccine in a steady supply, unwavering in our efforts “In a tweet, Bharat Biotech said.

Andhra Pradesh, Delhi, Bihar, Gujarat, Haryana, Uttar Pradesh, and West Bengal are among the states, according to the Hyderabad-based company.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Latest

National Doctors’ Day 2022: Background, Importance, and Theme – Everything You Need To Know

India will observe National Doctors' Day in 2022 to honour the dedication of the medical community, which works diligently to save millions of lives. National...

Covid-19 fourth wave scare looms over India, Health Minister to review situation today

The Union Health Minister will chair a review meeting on Thursday to discuss the increase in the number of COVID-19 cases in the country. Union...

Coronavirus New Cases: Corona’s speed started to scare again, 24 people died in 24 hours, 7,584 new cases

In a single day, 7,584 new cases of Covid-19 have been reported in the country. During this, 24 people have also died. The total...

Coronavirus in India: New cases of corona virus again increased tension, more than 4 thousand cases were reported for the second consecutive day

Coronavirus Updates: A total of 4518 new cases of Covid-19 have been reported in India in the last 24 hours and more than 4200...

Coronavirus Update: 2,745 new Covid-19 cases in last 24 hours

Covid-19 Update: As per the data shared by the Union Health Ministry on Wednesday (June 1), 2,745 new cases of coronavirus have been registered...

Most Popular

Subscribe

* indicates required